Posttransplant Donor-specific T-lymphocytotoxic Antibody in Liver Transplant Patients with a Positive Crossmatch
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Clinical significance of donor-specific human leukocyte antigen antibodies in liver transplantation.
Cuadrado A, San Segundo D, Lopez-Hoyos M, Crespo J, Fabrega E World J Gastroenterol. 2015; 21(39):11016-26.
PMID: 26494958 PMC: 4607901. DOI: 10.3748/wjg.v21.i39.11016.
Antibody-mediated rejection as a contributor to previously unexplained early liver allograft loss.
OLeary J, Kaneku H, Demetris A, Marr J, Shiller S, Susskind B Liver Transpl. 2014; 20(2):218-27.
PMID: 24382837 PMC: 4623588. DOI: 10.1002/lt.23788.
References
1.
Takaya S, Iwaki Y, Starzl T
. Liver transplantation in positive cytotoxic crossmatch cases using FK506, high-dose steroids, and prostaglandin E1. Transplantation. 1992; 54(5):927-9.
PMC: 2965439.
DOI: 10.1097/00007890-199211000-00031.
View
2.
Takaya S, Bronsther O, Iwaki Y, Nakamura K, Abu-Elmagd K, Yagihashi A
. The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors. Transplantation. 1992; 53(2):400-6.
PMC: 2978647.
DOI: 10.1097/00007890-199202010-00026.
View
3.
Nakamura K, Yagihashi A, Iwaki Y, Takaya S, Hartman G, Murase N
. The lymphocytotoxic crossmatch in liver transplantation: a clinicopathologic analysis. Transplant Proc. 1991; 23(6):3021-2.
PMC: 3082457.
View